Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: J Crit Care. 2018 Aug 16;48:26–31. doi: 10.1016/j.jcrc.2018.08.009

Table 3.

Hazard ratios for 60-day mortality by quintile of % change in high sensitivity troponin I levels between the day of intubation (day 0) and day 3.

Quintile of % change in hs-troponin between day 0 and day 3 (range)
First (−98.5 to −81.8%) Second (−81.8 to −67.6%) Third (−67.6 to −40.7%) Fourth (−40.7 to 32.1%) Fifth (>32.1%) P trend
Number of participants 181 182 181 182 182
Mean hs-troponin at day 0, ng/L 1,843.2 1,947.6 362.8 569.2 173.0
Mean hs-troponin at day 3, ng/L 178.7 470.2 158.5 403.2 721.7
Mean change in hs-troponin (%) −89.1 −75.4 −56.7 −10.3 1,442.2
Number of deaths (%) 27 (14.9) 34 (18.7) 49 (27.1) 47 (25.8) 68 (37.4)
Model 1
 Hazard ratio (95% confidence interval) 1.00 (reference) 1.40 (0.84 – 2.35) 2.14 (1.32 – 3.49) 2.35 (1.41 – 3.91) 3.88 (2.39 – 6.32) <0.001
Model 2
 Hazard ratio (95% confidence interval) 1.00 (reference) 1.42 (0.80 – 2.49) 1.99 (1.16 – 3.41) 2.11 (1.20 – 3.70) 3.22 (1.86 – 5.59) <0.001
Model 3
 Hazard ratio (95% confidence interval) 1.00 (reference) 1.28 (0.72 – 2.27) 1.67 (0.96 – 2.89) 1.63 (0.92 – 2.90) 2.27 (1.29 – 3.99) 0.002

Values in the Table were calculated using multiple imputation to take missing data into account (see Supplemental Table 1 for description of data available for each variable).

Model 1: Adjusted for age, sex, randomized trial assignment, and hs-troponin levels at day 0 (quintiles).

Model 2: Further adjusted for SOFA score at day 0.

Model 3: Further adjusted for use of vasopressors at day 0 and day 3, heart rate at day 0 and day 3, and total fluid balance between day 0 and day 3 (continuous).